Medivir AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
October 27, 2023 at 12:00 pm IST
Medivir AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was SEK 0.8 million compared to SEK 1.1 million a year ago. Revenue was SEK 1 million compared to SEK 2 million a year ago. Net loss was SEK 23.6 million compared to SEK 14.8 million a year ago. Basic loss per share from continuing operations was SEK 0.42 compared to SEK 0.27 a year ago. Diluted loss per share from continuing operations was SEK 0.42 compared to SEK 0.27 a year ago.
For the nine months, sales was SEK 3.2 million compared to SEK 2.1 million a year ago. Revenue was SEK 4.3 million compared to SEK 3.8 million a year ago. Net loss was SEK 69.1 million compared to SEK 70.7 million a year ago. Basic loss per share from continuing operations was SEK 1.23 compared to SEK 1.27 a year ago. Diluted loss per share from continuing operations was SEK 1.23 compared to SEK 1.27 a year ago.